Who
Nicola Deidre Petal Greenway
Chief Human Resources Officer
Company insider
Files Form 4 as: Chief Human Resources Officer, Takeda Pharmaceutical Company.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $1.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2026
- Last trade
- 18 Aug 2026
- Last filed
- 19 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Aug 2026filed 19 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $235K12,980 at $18.11 | filing |
| 18 Aug 2026filed 19 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $235K12,980 at $18.11 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $17K975 at $17.50 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $589K33,628 at $17.51 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $17K975 at $17.50 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $589K33,628 at $17.51 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $116K6,774 at $17.10 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $116K6,774 at $17.10 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —22,570 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —22,570 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.